The Patent Finder
RP

RQX Pharmaceuticals, Inc.

First filing 2013
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Two patents currently held, every record listed here

2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in May 2032. from the record

Of the 2 now held by other companies, 2 name Genentech Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2032
Next term end
2
Patent families

When these terms end

Each bar runs from grant to computed term end. 2016 to 2036.
US 10,501,493 Broad Spectrum Antibiotics May 25, 2032
US 9,309,285 Macrocyclic Broad Spectrum Antibiotics Nov 21, 2033
US 10,392,422 Macrocyclic Broad Spectrum Antibiotics May 19, 2035
US 11,072,635 Macrocyclic Broad Spectrum Antibiotics no later than Nov 21, 2036
20202024202820322036
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
1 pending application: term is not computable until grant.Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.

Formerly held, still cited

Notable
The earliest of the three still in force, granted 2019 and renewed since. Its term ends first, in 2035.
now held by Genentech, Inc.
Ends May 2035 · High confidence
Also notable
The newest of the three, granted 2021. It anchors the portfolio to 2036, later than anything else here. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
now held by Genentech, Inc.
Ends no later than Nov 2036 · Medium confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 10, 2027
    The maintenance fee for Broad Spectrum Antibiotics (US 10,501,493) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
  • 1 fee due Oct 12, 2027
    The maintenance fee for Macrocyclic Broad Spectrum Antibiotics (US 9,309,285) comes due Oct 12, 2027. Unpaid by Apr 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 1 largest of its 2 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Broad Spectrum Antibiotics1 in forceto May 2032

Patents held now

Soonest term end first.

Showing 1 to 2 of 2

PatentTitleStatusExpiresConfidence
US 10,501,493Broad Spectrum Antibiotics
In force
 · High confidence
In forceHigh confidence
US 9,309,285Macrocyclic Broad Spectrum Antibiotics
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 2: 2 patents in force now held by others · 2 patents ended · 1 application pending · 11 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited